<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251004067496N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-08</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Radiographic and clinical comparison of buccal gap filling methods in immediate implants.</public_title>
      <acronym></acronym>
      <scientific_title>Radiographic and clinical comparison in 4 methods of filling the buccal gap of immediate dental implants using l-PRF،ePRF،Xenograft and without gap filling a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>68</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86824</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization is performed using software and a sealed envelope tool is used. Blinding is performed during the clinical data collection phase (soft tissue thickness measurement is performed by a dentist who is unaware of the grouping before surgery) and review of scan files and statistical analysis.
The person taking the radiographic measurements is also unaware of the study grouping (only after 3 months of surgery is the xenograft group distinguished from the other groups due to the observation of bone particles on the radiograph). 
The participants in the study are not blinded, Blinding description: during the clinical data collection phase (soft tissue thickness measurement is performed by a dentist who is unaware of the grouping before surgery) and review of scan files and statistical analysis.
The person taking the radiographic measurements is also unaware of the study grouping (only after 3 months of surgery is the xenograft group distinguished from the other groups due to the observation of bone particles on the radiograph). 
The participants in the study are not blinded.</study_design>
      <phase>3</phase>
      <hc_freetext>People with systemic health conditions.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the Xenograft group, cera bone with particle sizes of 150-1000 microns was hydrated in normal saline for 10 minutes and packed in the buccal gap area up to the bone crest area. Intervention 2: Intervention group: In the L-PRF group, after blood collection from the brachial artery, it is placed in 2 red 9 ml test tubes in a centrifuge at 2700 rpm for 12 minutes. After this time, the obtained L-PRF is separated from the red blood cells and packed by the special area in the PRF kit to produce L-PRF plug. Intervention 3: Intervention grouIn the buccal gap filling e-PRF group, after blood collection from the brachial artery in a 9 ml white test tube, it is centrifuged at 700 rpm for 8 minutes. After that, to prepare e-PRF, first 2 ml of the liquid was obtained. In the test tube, which is PPP (platelet poor plasma), it is aspirated using a 3 ml locking syringe And this syringe is placed in a heater for 10 minutes at 75°C to coagulate the proteins. During this time, the test tubes are placed in the refrigerator to prevent coagulation. After ten minutes, the syringes are removed from the heater and placed in the refrigerator to reach room temperature, and the centrifuge tubes are removed from the refrigerator and their plastic lids are opened and the L-PRF layer and buffy coat are aspirated using a locking syringe. The syringe containing the PPP is coagulated and PRF is connected using the syringe connector, and the contents of the syringe are mixed and injected into the buccal gap and packed up to the gingival margin using a condenser. Intervention 4: Control group: In the control group, no material is placed in the buccal gap.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Batool Mahmoodi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shafa street, Kerman Dental School, Periodontology Department</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7618759689</zip>
        <telephone>03432119021-4</telephone>
        <email>batoolmahmoodi74@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nazila Lashkarizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shafa street, Kerman Dental School, Periodontology Department</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7618759689</zip>
        <telephone>+98 34 3211 9021</telephone>
        <email>n_lashkarizadeh@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Systemically healthy patient
Patients who are at least 18 years old
The tooth socket must be type 1 (buccal soft tissue and buccal and lingual bone plates must be intact)
Non-molar teeth that cannot be maintained
Immediate implant placement (achieving initial stability of at least 35Ncm) is possible without moving the flap and there is sufficient intraocclusal space.
It is possible to place an implant fixture with a horizontal buccal gap greater than 2 mm.
A person with adequate oral hygiene with a plaque index less than or equal to 20 percent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>People who smoke or are addicted to drugs or alcohol
People who are pregnant or have systemic diseases such as diabetes, or if they are taking antibiotics or drugs that weaken the immune system such as corticosteroids.
Probing depth greater than three millimeters buccally or lingually
The need for bone grafting at the same time as implant placement
Presence of local or systemic conditions that are contraindications to implant placement</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the Xenograft group, cera bone with particle sizes of 150-1000 microns was hydrated in normal saline for 10 minutes and packed in the buccal gap area up to the bone crest area.</i_keyword>
      <i_keyword>Intervention group: In the L-PRF group, after blood collection from the brachial artery, it is placed in 2 red 9 ml test tubes in a centrifuge at 2700 rpm for 12 minutes. After this time, the obtained L-PRF is separated from the red blood cells and packed by the special area in the PRF kit to produce L-PRF plug.</i_keyword>
      <i_keyword>Intervention grouIn the buccal gap filling e-PRF group, after blood collection from the brachial artery in a 9 ml white test tube, it is centrifuged at 700 rpm for 8 minutes. After that, to prepare e-PRF, first 2 ml of the liquid was obtained. In the test tube, which is PPP (platelet poor plasma), it is aspirated using a 3 ml locking syringe And this syringe is placed in a heater for 10 minutes at 75°C to coagulate the proteins. During this time, the test tubes are placed in the refrigerator to prevent coagulation. After ten minutes, the syringes are removed from the heater and placed in the refrigerator to reach room temperature, and the centrifuge tubes are removed from the refrigerator and their plastic lids are opened and the L-PRF layer and buffy coat are aspirated using a locking syringe. The syringe containing the PPP is coagulated and PRF is connected using the syringe connector, and the contents of the syringe are mixed and injected into the buccal gap and packed up to the gingival margin using a condenser.</i_keyword>
      <i_keyword>Control group: In the control group, no material is placed in the buccal gap.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Buccal bone thickness (post-surgery): Linear measurement of the distance between the external surface of the bone and the implant shoulder at distances of 0, 2, 4, and 6 mm from the implant shoulder perpendicular to the long axis of the implant. Timepoint: At the beginning of the study and 3 months after surgery. Method of measurement: Measurements of the width of the socket in the coronal and apical sections, perpendicular to the longitudinal axis of the socket, are made linearly on the 3D image DIACOM file, by a person who is unaware of the grouping.</prim_outcome>
      <prim_outcome>Implant coverage by bone: Percentage of implant height covered by bone in the buccal areas. Timepoint: 3 months after surgery. Method of measurement: Bone thickness and height (percentage of implant covered by bone both buccally and lingually) are performed linearly on the 3D image dycom file by a person who is unaware of the grouping.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Soft tissue thickness. Timepoint: Beginning of the intervention and three months later. Method of measurement: Endo file and gauge.</sec_outcome>
      <sec_outcome>Distance of the gingival margin from the edge of the healing abutment. Timepoint: Beginning of the intervention and three months later. Method of measurement: Periodontal probe, parallel to the longitudinal axis of healing.</sec_outcome>
      <sec_outcome>Keratinized gingival width. Timepoint: Beginning of the intervention and three months later. Method of measurement: Periodontal probe.</sec_outcome>
      <sec_outcome>Soft tissue contour. Timepoint: Before the intervention and three months later. Method of measurement: Preparation of a digital file of the buccal soft tissue contour in format standard tessellation language and superimposition format to examine changes in the soft tissue contour.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-11-10</approval_date>
        <contact_name>Ethics Committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Research Ethics Committee, Kerman University of Medical Sciences, Beginning of Haft Bagh Alavi Axis, University of Medical Sciences Campus Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
